Vext Science, Inc.
VEXTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.12 | 0.02 | 0.28 |
| FCF Yield | 6.69% | 4.77% | -11.75% | -10.19% |
| EV / EBITDA | -30.75 | 3.76 | 3.81 | 6.05 |
| Quality | ||||
| ROIC | -9.53% | -1.66% | 12.83% | 8.63% |
| Gross Margin | 24.94% | 34.58% | 65.23% | 50.17% |
| Cash Conversion Ratio | -0.15 | 1.01 | 0.54 | 2.34 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.55% | -2.23% | 12.02% | 18.60% |
| Free Cash Flow Growth | 8.04% | 157.45% | 58.64% | -636.07% |
| Safety | ||||
| Net Debt / EBITDA | -17.27 | 1.72 | 2.14 | 0.60 |
| Interest Coverage | -2.85 | -0.47 | 4.35 | 4.25 |
| Efficiency | ||||
| Inventory Turnover | 2.03 | 1.86 | 0.89 | 86.37 |
| Cash Conversion Cycle | 147.70 | 251.73 | 587.24 | 207.47 |